MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity
- PMID: 13679281
- PMCID: PMC7974011
MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity
Abstract
We describe a case demonstrating reversible MR imaging findings, including diffusion-weighted imaging changes in association with metronidazole (Flagyl) toxicity. The diagnosis of metronidazole toxicity was made clinically and supported by the MR imaging findings. Quantitative apparent diffusion coefficient (ADC) maps demonstrated edema with associated increased ADC values within the dentate nuclei of the cerebellum on initial imaging. Follow-up imaging performed 8 weeks after cessation of metronidazole therapy demonstrated resolution of imaging findings, including diffusion changes.
Figures


References
-
- Kusumi RK, Plouffe JF, Wyat RH, Fass RJ. Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med 1980;93:59–60 - PubMed
-
- Ahmed A, Loes DJ, Bressler EL. Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy. Neurology 1995;45:588–589 - PubMed
-
- Horlen CK, Seifert CF, Malouf CS. Toxic metronidazole-induced MRI changes. Ann Pharmacother 2000;34:1273–1275 - PubMed
-
- Von Rogulija P, Kovac W, Schmid H. Metronidazole encephalopathy in rats. Acta Neuropathol 1973;25:36–44 - PubMed
-
- Frytak S, Moertel CG, Childs DS. Neurologic toxicity associated with high dose metronidazole therapy. Ann Intern Med 1978;88:361–362 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical